Amicus Therapeutics, Inc. (AM6.F)
| Previous Close | 9.50 |
| Open | 9.65 |
| Bid | 9.65 x 50000 |
| Ask | 9.90 x 50000 |
| Day's Range | 9.65 - 9.65 |
| 52 Week Range | 9.25 - 13.20 |
| Volume | |
| Avg. Volume | 17 |
| Market Cap | 2.931B |
| Beta (5Y Monthly) | 0.76 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.48 |
| Earnings Date | May 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.90 |
ZacksWill Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know
Amicus Therapeutics (FOLD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GlobeNewswireAmicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, May 9, 2024, at 8:30 a.m. ET to discuss financial results for the first quarter ended March 31, 2024. Participants and investors interested in accessing the call by phone will need to register using the online registration form. After registering, all phone participants will receive a dial-in number along with a pers
Simply Wall St.When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable?
Amicus Therapeutics, Inc. ( NASDAQ:FOLD ) is possibly approaching a major achievement in its business, so we would like...
